Infinity Fundamentals

INFI -  USA Stock  

USD 1.11  0.07  5.93%

Infinity Pharmaceuti fundamentals help investors to digest information that contributes to Infinity Pharmaceuti's financial success or failures. It also enables traders to predict the movement of Infinity Stock. This fundamental analysis module provides a way for investors to measures Infinity Pharmaceuti's intrinsic value by examining all of its available economic and financial indicators and drivers, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Infinity Pharmaceuti stock. Please note, this module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Infinity Fundamentals 

 
Refresh
Infinity Pharmaceuti Revenues is most likely to decrease significantly in the upcoming years. The last year's value of Revenues was reported at 1.55 Million. The current Research and Development Expense is estimated to increase to about 24.7 M, while Consolidated Income is projected to decrease to (50.2 M).

Infinity Number of Shares Shorted Analysis

Infinity Pharmaceuti's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
 2019 2020 2021 2022 (projected)
Interest Expense2.56 M2.44 M2.2 M2.19 M
Gross Profit3.05 M1.72 M1.55 M1.59 M
Shares Shorted 
 = 
Shorted by Public 
by Institutions 
More About Number of Shares Shorted | All Equity Analysis

Current Infinity Pharmaceuti Number of Shares Shorted

    
  2.74 M  
Most of Infinity Pharmaceuti's fundamental indicators, such as Number of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Infinity Pharmaceuti is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Compare to competition

Based on the recorded statements, Infinity Pharmaceuti has 2.74 M of outstending shares currently sold short by investors. This is 14.35% lower than that of the Healthcare sector and 46.25% lower than that of the Biotechnology industry. The number of shares shorted for all United States stocks is 41.77% higher than that of the company.

Infinity Pharmaceuti Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Infinity Pharmaceuti's current stock value. Our valuation model uses many indicators to compare Infinity Pharmaceuti value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Infinity Pharmaceuti competition to find correlations between indicators driving Infinity Pharmaceuti's intrinsic value. More Info.
Infinity Pharmaceuti is considered the number one company in total debt category among related companies. It is currently regarded as number one stock in earnings per share category among related companies . Infinity Pharmaceuti Total Debt is most likely to decrease significantly in the upcoming years. The last year's value of Total Debt was reported at 1.29 Million. Comparative valuation analysis is a catch-all model that can be used if you cannot value Infinity Pharmaceuti by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Infinity Pharmaceuti's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Infinity Pharmaceuti's earnings, one of the primary drivers of an investment's value.

Infinity Pharmaceuti Current Valuation Drivers

We derive many important indicators used in calculating different scores of Infinity Pharmaceuti from analyzing Infinity Pharmaceuti's financial statements. These drivers represent accounts that assess Infinity Pharmaceuti's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Infinity Pharmaceuti's important valuation drivers and their relationship over time.
201720182019202020212022 (projected)
Net Income Per Employee(1.9 M)(450.12 K)(1.88 M)(1.76 M)(2.02 M)(2.07 M)
Revenue Per Employee272.73 K885.84 K121.96 K74.53 K85.72 K87.97 K
Average Assets79.52 M56.84 M62.83 M48.01 M43.21 M44.34 M
Earnings Before Interest Taxes and Depreciation Amortization EBITDA(39.83 M)(10.97 M)(44.33 M)(37.56 M)(43.2 M)(46.61 M)
Earnings Before Interest Taxes and Depreciation Amortization USD(39.83 M)(10.97 M)(44.33 M)(37.56 M)(43.2 M)(46.61 M)
Earnings before Tax(42.55 M)(11.25 M)(47.11 M)(40.49 M)(46.57 M)(50.24 M)
Average Equity58.45 M50.8 M23.83 M(12.69 M)(11.42 M)(11.72 M)
Enterprise Value75.36 M34.89 M34.8 M119.15 M107.24 M110.06 M
Free Cash Flow(36 M)(4.71 M)(43.86 M)(35.78 M)(41.15 M)(44.4 M)
Invested Capital19.15 M3.88 M18.98 M1.11 M1 M1.03 M
Invested Capital Average29 M10.69 M20.72 M13.29 M11.96 M12.27 M
Market Capitalization102.94 M67.1 M54.75 M136.12 M122.51 M125.73 M
Tangible Asset Value59.35 M60.22 M49.01 M39.32 M35.39 M36.32 M
Working Capital46.79 M52.1 M34.88 M24.97 M22.48 M23.07 M

Infinity Pharmaceuti Institutional Holders

Institutional Holdings refers to the ownership stake in Infinity Pharmaceuti that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Infinity Pharmaceuti's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Infinity Pharmaceuti's value.
Security TypeSharesValue
Callan Capital LlcCommon Shares146.2 K329 K
Russell Investments Group LtdCommon Shares37.9 K85 K
Cutler Group LpCommon Shares9.3 K20 K
National Bank Of CanadaCommon Shares2.6 KK
Koshinski Asset Management IncCommon SharesK4.5 K
Cutler Group LpPut Options7001000
Cutler Group LpCall Options3000.0
Tci Wealth Advisors IncCommon Shares2000.0
Bvf IncCommon Shares8.4 M28.7 M

Infinity Fundamentals

About Infinity Pharmaceuti Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Infinity Pharmaceuti's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Infinity Pharmaceuti using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Infinity Pharmaceuti based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2022
Deferred Revenue164.7 K169 K
Revenues1.5 M1.6 M
Revenue to Assets 0.05  0.05 
Revenue Per Employee85.7 K88 K
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Infinity Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Cambridge, Massachusetts. Infinity Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 23 people.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Infinity Pharmaceuti without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Transaction History Now

   

Transaction History

View history of all your transactions and understand their impact on performance
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Infinity Pharmaceuti using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please see Infinity Pharmaceuti Piotroski F Score and Infinity Pharmaceuti Altman Z Score analysis. Note that the Infinity Pharmaceuti information on this page should be used as a complementary analysis to other Infinity Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for Infinity Stock analysis

When running Infinity Pharmaceuti price analysis, check to measure Infinity Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuti is operating at the current time. Most of Infinity Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Infinity Pharmaceuti's price. Additionally, you may evaluate how the addition of Infinity Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Go
Is Infinity Pharmaceuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Infinity Pharmaceuti. If investors know Infinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Infinity Pharmaceuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Infinity Pharmaceuti is measured differently than its book value, which is the value of Infinity that is recorded on the company's balance sheet. Investors also form their own opinion of Infinity Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Infinity Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Infinity Pharmaceuti's market value can be influenced by many factors that don't directly affect Infinity Pharmaceuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Infinity Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Infinity Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infinity Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.